Global D-Calcium Pantothenate Market Overview:
D-calcium pantothenate is a synthetic substance made from pantothenic acid and supplement of vitamin B-5. D-calcium pantothenate market is expected to grow in the future due to increasing deficiency of vitamin B-5 and rising obesity cases globally. In additional, adoption of D-calcium pantothenate among the millennial to clear up their skin boosting the demand of the D-calcium pantothenate. Increasing health consciousness and expenditure related to health care product boosting the growth of the market.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Adoption of D-Calcium Pantothenate among Millennial to Clear Up their Skin
Market Growth Drivers:
Increasing Obesity Cases Globally, Increasing Preveleance of Vitamin B5 Deficiency and Rising Demand from Consumer to Reduce the Bad Cholesterol
Challenges:
Availability of Substitutes such as Herbal Products and High Production Cost
Restraints:
Stringent Government Regulation for D-Calcium Pantothenate
Opportunities:
Increasing Health Consciousness among the Population and Rising Demand from the Developing Economies
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Shanghai Freemen (United States), DSM (Netherlands), BASF (Germany), Yifan Pharmaceutical (China), Xinfa Pharmaceutical (China), Huachen Pharmaceutical (China), Zhejiang Chemvplus Biotech (China), Global Calcium Pvt Ltd (India) and A.M Food Chemical Co. Limited(China). Additionally, following companies can also be profiled that are part of our coverage like Merck KGaA (Germany) and Supreem Pharmaceuticals Mysore Pvt. Ltd.(India). Analyst at AMA Research see Chinese Players to retain maximum share of Global D-Calcium Pantothenate market by 2028.
Latest Market Insights:
In October 2021, BASF SE, another major German chemical company, entered into a strategic partnership with Niacet Corporation, a leading producer of D-Calcium Pantothenate in the United States. The partnership aims to enhance the supply of D-Calcium Pantothenate to the animal feed industry in North America.
In August 2021, Evonik Industries AG, a German chemical company, announced the expansion of its D-Calcium Pantothenate production facility in Antwerp, Belgium. The expansion will increase the plant's capacity by 50%, making it the largest D-Calcium Pantothenate production facility in Europe.
What Can be Explored with the D-Calcium Pantothenate Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global D-Calcium Pantothenate Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in D-Calcium Pantothenate
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global D-Calcium Pantothenate market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in D-Calcium Pantothenate market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of D Calcium Pantothenate, Raw Material Suppliers, Market Research and Consulting Firms, Government Bodies and Potential Investor.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.